▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2972 by analyst upside · 2026-06-27
FMS
Fresenius Medical Care AG
Healthcare · Market Cap $12B · P/E 12.5x
ANALYST PRICE TARGET
+9.2%
implied upside to consensus target
Current Price $23.24
Consensus Target $25.39
Bull Target $37.24
Bear Target $17.61
Analysts Covering 6
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
2
Hold
3
Sell
1
52-Week Low $20.02
52-Week High $28.87
YTD Return +2.8%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) 12.5x
Forward P/E 6.0x
EPS (TTM) $1.86
PEG Ratio 0.85
Dividend Yield 3.75%
Revenue (TTM) $19.4B
Profit Margin 4.9%
52-WEEK RANGE
52-Week Low $20.02
52-Week High $28.87
Current Price $23.24
Bear Target $17.61
Bull Target $37.24
● Now $23.24 ● Target $25.39
TRADING DATA
Avg Volume 718K
YTD Return +2.8%
Analyst Count 6
Consensus Hold
Upside to Target +9.2%
Last Updated 2026-06-27

ANALYST SUMMARY

Fresenius Medical Care AG (FMS) is currently trading at $23.24 with a Wall Street consensus price target of $25.39, implying potential upside of 9.2% over the next 12 months. 6 analysts currently cover FMS, with a consensus rating of Hold — 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $37.24, while the most cautious has a target of $17.61.

FMS operates in the Healthcare sector with a market capitalisation of $12B. The stock is up 2.8% year-to-date and is currently trading near the lower end of its 52-week range of $20.02 – $28.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

SNN +16.5%
Smith & Nephew plc
$13B · P/E 21.0x · Hold
SOLV +3.3%
Solventum Corporation
$14B · P/E 9.5x · Hold
ALGN +17.2%
Align Technology, Inc.
$13B · P/E 29.9x · Buy
GMED +26.0%
Globus Medical, Inc.
$12B · P/E 20.2x · Buy
RDY -6.9%
Dr. Reddy's Laboratories Limited
$13B · P/E 28.5x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for FMS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ↓ Downgrade
Neutral → Sell 2025-09-02 33% win rate (6 calls)
Truist Securities — Reiterated
Hold → Hold 2025-05-12 Building track record
Truist Securities — Reiterated
Hold → Hold 2025-01-06 Building track record
Truist Securities — Reiterated
Hold → Hold 2024-10-07 Building track record
Truist Securities — Reiterated
Hold → Hold 2024-07-31 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →